Natural Killer Cells and Bortezomib to Treat Cancer

Clinical trial NCT00720785 · COMPLETED

Trial details

NCT number: NCT00720785
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia (CML)Pancreatic Ca Colon/Rectal Ca Multiple Myeloma Carcinoma, Non-Small -Cell Lung

Start date: 2008-08-01
Primary completion: 2021-04-06
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.